| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advancing inclusive healthcare through PBPK modelling: predicting the impact of CYP genotypes and enzyme ontogenies on infant exposures of venlafaxine and its active metabolite O-desmethylvenlafaxine in lactation
|
Pan, Xian
|
|
|
52 |
2 |
|
artikel
|
| 2 |
Defining preclinical efficacy with the DNAPK inhibitor AZD7648 in combination with olaparib: a minimal systems pharmacokinetic–pharmacodynamic model
|
DeJongh, Joost
|
|
|
52 |
2 |
|
artikel
|
| 3 |
Imputation of missing clock times – application to procalcitonin concentration time course after birth
|
Bokor, Abigail J.
|
|
|
52 |
2 |
|
artikel
|
| 4 |
Information-theoretic evaluation of covariate distributions models
|
Hartung, Niklas
|
|
|
52 |
2 |
|
artikel
|
| 5 |
Interoccasion variability in population pharmacokinetic models: identifiability, influence, interdependencies and derived study design recommendations
|
Behrens, Emily
|
|
|
52 |
2 |
|
artikel
|
| 6 |
Reliability of in vitro data for the mechanistic prediction of brain extracellular fluid pharmacokinetics of P-glycoprotein substrates in vivo; are we scaling correctly?
|
van Valkengoed, Daan W.
|
|
|
52 |
2 |
|
artikel
|
| 7 |
Sampling from covariate distribution may not always be necessary in PK/PD simulations: illustrative examples with antibiotics
|
Liu, Feiyan
|
|
|
52 |
2 |
|
artikel
|
| 8 |
The impact of misspecified covariate models on inclusion and omission bias when using fixed effects and full random effects models
|
Nyberg, Joakim
|
|
|
52 |
2 |
|
artikel
|
Tijdschrift beschrijving